Compare DXCM & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXCM | LI |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9B | 13.4B |
| IPO Year | 2005 | 2019 |
| Metric | DXCM | LI |
|---|---|---|
| Price | $88.41 | $12.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 10 |
| Target Price | ★ $85.33 | $19.66 |
| AVG Volume (30 Days) | ★ 5.2M | 3.0M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.18 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.46 | $18.98 |
| Revenue Next Year | $12.31 | $22.72 |
| P/E Ratio | $78.04 | ★ $29.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.11 | $11.65 |
| 52 Week High | $91.99 | $26.94 |
| Indicator | DXCM | LI |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 43.47 |
| Support Level | $62.02 | $12.06 |
| Resistance Level | N/A | $13.16 |
| Average True Range (ATR) | 2.72 | 0.25 |
| MACD | 0.64 | -0.04 |
| Stochastic Oscillator | 81.39 | 10.78 |
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.